The agreement will lower tariffs, boost semiconductor manufacturing in the U.S., and provide credit guarantees for Taiwanese companies. ...

PresentationGood morning, everyone. I hope everyone's had a good week. Welcome to the 44th Annual JPMorgan Healthcare Conference. My name is Cliff, a member of the Healthcare Investment Banking team. And our next presenting company is Veracyte. Speaking on behalf of the company, I'm pleased to have CEO, Marc Stapley. Please give it up for Marc.Marc StapleyCEO & Director Thank you, Cliff. Good morning. We're very pleased to be here at the JPMorgan Healthcare Conference. Thank you for joining us. So before I ...

PresentationHi, everyone. Thank you so much for joining us today. My name is [ Lina Campbell ] and I am an associate with the health care investment banking team at JPMorgan. It's my great pleasure to introduce Joe DeVivo, the CEO, President and Chairman; and John Doherty, EVP, Chief Financial Officer; and Megan Carlson, the Chief Accounting Officer of the Butterfly Network team. Please join me welcome the team here.Joseph DeVivoCEO, President & Chairman of the Board All right. Well, first of all, thank you ...

PresentationGood morning, everyone. Welcome. We're excited to be continuing our 44th Annual JPMorgan Healthcare Conference. My name is Roland Ye. I'm associate on the health care investment banking team. And today, it's my pleasure to introduce Corbus Pharmaceuticals and CEO, Yuval Cohen. We'll have time for Q&A at the end. And with that, we'll hand it over to Yuval.Yuval CohenCEO & Director Good morning, everyone. Roland, thank you so much for that introduction. It's a delight to be here. We're very gratef ...

PresentationGood morning, everyone. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the Senior Biotech Analysts here at the firm. On stage, we have CG Oncology. I will now pass the mic to their CEO, Arthur Kuan for a short presentation followed by a live audience Q&A. Arthur, welcome. The stage is yours.Arthur KuanChairman & CEO Thank you, Brian. Good morning, everyone. So at CG Oncology, we're laser-focused on one mission, and that is we're ...

Oracle Corporation (NYSE:ORCL) is one of the Must-Watch AI Stocks on Wall Street. On January 12, Goldman Sachs analyst Gabriela Borges assumed coverage on the stock with a “Buy” rating and a set a price target of $240. Firm analysts are bullish on Oracle’s compute advantage, anticipating gross profit acceleration. Borges noted how the firm is positive on Oracle’s technology advantage in AI compute workloads and its potential to increase share of new cloud revenue from less than 10% today to an estimated ...

Under the agreement, Taiwan Semiconductor Manufacturing will add new factories to its cluster in Arizona as part of a $250 billion investment in the U.S., the Commerce Department said. ...

Blackstone is providing 4 billion euros ($4.65 billion) for a data center in Lippetal, Germany, Handelsblatt reported on Thursday, citing sources. ...

Core Viewpoint - Fortinet (FTNT) stock is experiencing positive momentum due to a rally in the tech sector, driven by strong earnings from Taiwan Semiconductor Manufacturing (TSM) [1] Group 1: Stock Performance - FTNT shares are set to end a three-day losing streak but have a 26.8% deficit over the past three months, recently hitting a two-month low [1] - The stock has support at the $76 level, which has previously contained pullbacks in August, September, and November [1] - FTNT is currently within 3% of its 40-month moving average, having closed above this trendline for the past five months [2] Group 2: Historical Trends - Historical data shows that when FTNT is within 3% of its 40-month moving average, the stock has risen one month later 86% of the time, with an average gain of 3.1% [2] - Over a three-month period, FTNT has averaged a 10.9% gain with a 71% win rate following similar signals [2] Group 3: Analyst Ratings - Current analyst ratings for FTNT include 30 "hold," 7 "strong buy," and 4 "sell" or worse, indicating a cautious outlook among analysts [4] - A surge in FTNT stock could prompt some brokerages to adopt a more bullish stance [4] Group 4: Volatility Assessment - FTNT has a Schaeffer's Volatility Scorecard (SVS) of 21 out of 100, suggesting it has experienced lower volatility than its options pricing over the past year [5] - This low volatility indicates that a premium-selling strategy may be advantageous moving forward [5]

ToplineParamount Skydance discussed its hostile $108 billion bid for Warner Bros. Discovery with French President Emmanuel Macron this week as the company seeks support from European officials, Bloomberg reported Thursday, after Paramount said it would launch a proxy fight to prevent a merger with Netflix. Warner Bros. Discovery twice rejected an offer from Paramount backed by billionaire Larry Ellison. Getty ImagesKey FactsSenior executives from Paramount held talks with Macron and other senior French offi ...